Neuland also has other molecules ready for commercial sale in the next 3-4 years. That is the growth the market is anticipating at CMP. KarXT, while a blockbuster in itself, leaves many questions in terms of cashflows. Management themselves have mentioned repeatedly that this FY is one of moderation in margins.
Disc: invested
| Subscribe To Our Free Newsletter |
